1. Home
  2. ENTX vs KNDI Comparison

ENTX vs KNDI Comparison

Compare ENTX & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$2.16

Market Cap

142.0M

Sector

Health Care

ML Signal

N/A

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$1.03

Market Cap

92.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
KNDI
Founded
2010
2002
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
142.0M
92.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ENTX
KNDI
Price
$2.16
$1.03
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
76.2K
172.3K
Earning Date
11-14-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$124,000.00
$104,035,613.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.25
N/A
52 Week Low
$1.50
$0.89
52 Week High
$3.22
$1.81

Technical Indicators

Market Signals
Indicator
ENTX
KNDI
Relative Strength Index (RSI) 40.14 52.64
Support Level $2.07 $0.92
Resistance Level $2.27 $1.19
Average True Range (ATR) 0.19 0.05
MACD -0.02 0.02
Stochastic Oscillator 15.44 48.33

Price Performance

Historical Comparison
ENTX
KNDI

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: